Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.155
-0.035 (-2.94%)
Aug 28, 2026, 1:43 PM EDT - Market open
Milestone Pharmaceuticals Market Cap
Milestone Pharmaceuticals has a market cap or net worth of $162.75 million as of August 28, 2026. Its market cap has decreased by -6.08% in one year.
Market Cap
162.75M
Enterprise Value
133.98M
1-Year Change
-6.08%
Ranking
Category
Stock Price
$1.16
ChartMarket Cap Chart
Since May 9, 2019, Milestone Pharmaceuticals's market cap has decreased from $363.46M to $162.75M, a decrease of -55.22%. That is a compound annual growth rate of -10.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 162.75M | -20.68% |
| Dec 31, 2025 | 205.20M | 31.26% |
| Dec 31, 2024 | 156.32M | 117.39% |
| Dec 29, 2023 | 71.91M | -57.49% |
| Dec 30, 2022 | 169.15M | -38.80% |
| Dec 31, 2021 | 276.39M | 38.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Codexis | 181.78M |
| Molecular Partners AG | 178.74M |
| Caribou Biosciences | 177.96M |
| MediWound | 170.93M |
| Jyong Biotech | 170.74M |
| NRx Pharmaceuticals | 156.61M |
| Outlook Therapeutics | 156.07M |
| Tenaya Therapeutics | 155.88M |